Press Releases August 25, 2026 04:05 PM

Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026

Nanox Announces Q2 2026 Financial Results Release Date and Conference Call Details

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
NNOX

Nanox Imaging Ltd, a Nasdaq-listed medical imaging technology company, will release its Q2 2026 financial results before market open on September 9, 2026. The company will hold a conference call to discuss the results and provide a business update, highlighting its integrated medical imaging and AI healthcare platform.

Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026
NNOX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Nanox focuses on affordable, AI-driven medical imaging technology aimed at preventive healthcare.
  • The company integrates imaging hardware, AI algorithms, cloud analytics, remote radiology services, and health IT solutions.
  • Q2 2026 financial results and business update to be presented on September 9, 2026.

PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2026, before market open on Monday, September, 9, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Guy Nathanzon, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.

Interested parties may register for the conference call using the following link:  Nanox Q2 2026 Conference Call

The live webcast of the conference call may be accessed by using the following link: Nanox Q2 2026 Webcast

The webcast link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations. 

About Nanox

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.

Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.

Nanox’s vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.

The Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.

By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. For more information, please visit www.nanox.vision

Contacts

Investor Contact
Mike Cavanaugh
ICR Healthcare
[email protected]

Media Contact
ICR Healthcare
[email protected]


Risks

  • Financial results might not meet market expectations, leading to negative investor sentiment.
  • Regulatory challenges or delays in technology deployment could impact growth prospects.
  • Market adoption of new medical imaging technologies may be slower than anticipated.

More from Press Releases

Advasa Holdings, Inc. completed a direct listing on Nasdaq under the ticker symbol "ADBT" Aug 25, 2026 Greenland Mines Announces Proposed Public Offering Aug 25, 2026 Osisko Gold Announces CFO Transition to Support Its Next Stage of Growth Aug 25, 2026 F&M Bank Welcomes Gregory R. Allen to Board of Directors Aug 25, 2026 Renasant Announces Chief Financial Officer Transition Aug 25, 2026